Annual Reports

  • 20-F (Mar 6, 2018)
  • 20-F (Mar 7, 2017)
  • 20-F (Mar 8, 2016)
  • 20-F (Mar 10, 2015)
  • 20-F (Mar 20, 2014)
  • 20-F (Mar 25, 2013)

 
Other

AstraZeneca 20-F 2010
Exhibit 8.1

 
At December 31, 2009
 
 
Country
 
 
Percentage of voting share capital held (1)
 
 
Principal activity
UK
           
AstraZeneca UK Limited
 
England
 
100
 
Research and development, manufacturing, marketing
AstraZeneca Treasury Limited
 
England
 
100
 
Treasury
Continental Europe
           
NV AstraZeneca SA
 
Belgium
 
100
 
Marketing
AstraZeneca Dunkerque Production SCS
 
France
 
95
 
Manufacturing
AstraZeneca SAS
 
France
 
100
 
Research, manufacturing, marketing
AstraZeneca GmbH
 
Germany
 
100
 
Development, manufacturing, marketing
AstraZeneca Holding GmbH
 
Germany
 
100
 
Manufacturing, marketing
AstraZeneca SpA
 
Italy
 
100
 
Marketing
AstraZeneca Farmaceutica Spain SA
 
Spain
 
100
 
Marketing
AstraZeneca AB
 
Sweden
 
100
 
Research and development, manufacturing, marketing
AstraZeneca BV
 
The Netherlands
 
100
 
Marketing
The Americas
           
AstraZeneca Canada Inc.
 
Canada
 
100
 
Research, marketing
AZ Reinsurance Limited
 
Cayman Islands
 
100
 
Insurance and reinsurance underwriting
IPR Pharmaceuticals Inc.
 
Puerto Rico
 
100
 
Development, manufacturing, marketing
AstraZeneca LP
 
US
 
99
 
Research and development, manufacturing, marketing
AstraZeneca Pharmaceuticals LP
 
US
 
100
 
Research and development, manufacturing, marketing
Zeneca Holdings Inc.
 
US
 
100
 
Manufacturing, marketing
MedImmune, LLC
 
US
 
100
 
Research and development, manufacturing, marketing
Asia, Africa & Australasia
     
 
   
AstraZeneca Pty Limited
 
Australia
 
100
 
Development, manufacturing, marketing
AstraZeneca Pharmaceuticals Co., Limited
 
China
 
100
 
Research and development, manufacturing, marketing
AstraZeneca KK
 
Japan
 
80
 
Manufacturing, marketing


(1)   All shares are held indirectly.
 
 
The companies and other entities listed above are those whose results or financial position principally affected the figures shown in the Financial Statements of AstraZeneca PLC and its subsidiaries (the “Group”).  A full list of subsidiaries, joint ventures and associates will be annexed to AstraZeneca PLC’s next annual return filed with the Registrar of Companies.  The country of registration or incorporation is stated alongside each company. The accounting year ends of subsidiaries and associates are December 31, except for Aptium Oncology, Inc. which, owing to local conditions and to avoid undue delay in the preparation of the Financial Statements, is November 30.  The Company operates through 282 subsidiaries worldwide.  Products are manufactured in 18 countries worldwide and are sold in over 100 countries.  The Group Financial Statements consolidate the Financial Statements of the Company and its subsidiaries at December 31, 2009.
 


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki